Primary Site >> Pancreatic Cancer
Gene >> CUL9
|
|---|
|
Ref: Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283]. PMID: 16219105 |